H1N1 Vaccines Market By Vaccine Type, Route Of Administration and Distribution Channel - Global Industry Analysis And Forecast To 2027
Published On : November 2018 Pages : 180 Category: Pharmaceuticals Report Code : HC111678
H1N1 Vaccines Market By Vaccine Type (Live Attenuated Vaccine and Inactivated Vaccine), Route Of Administration (Intranasal Vaccine and Injectable Vaccine) and Distribution Channel (Online Pharmacy, Hospital Pharmacy and Retail Pharmacy) - Global Industry Analysis And Forecast To 2027
Industry Outlook
H1N1 is also referred to as Swine Flu, as the people who suffered from it where in direct contact with the pigs. The scenario changed after period of time when people started to get affected by the disease without being in contact with pigs. H1N1 was spreading fast in the year 2009, WHO termed it as a pandemic. Symptoms of H1N1 are similar to that of common flu that include; fever, cough, chills, fatigue, headaches, sore throat, etc. H1N1 can have widespread effect if not treated like; lung infection, pneumonia, breathing problems, etc. H1N1 Vaccines use is growing owing to factors like; increasing number of aged population, rising number of cases of the disease, increase in the initiatives by the government across the globe, seasonal occurrence seen in the H1N1 disease, etc. Therefore, the H1N1 Vaccines Market is anticipated to expand and has tremendous scope during the forecast period. The global H1N1 Vaccines Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global H1N1 Vaccines Market is based on segment, by Vaccine Type the market is segmented into Live Attenuated Vaccine and Inactivated Vaccine, by Route Of Administration the market is segmented into Intranasal Vaccine and Injectable Vaccine, and by Distribution Channel the market is segmented into Online Pharmacy, Hospital Pharmacy and Retail Pharmacy.
- H1N1 Vaccines Market, By Vaccine Type
- Live Attenuated Vaccine
- Inactivated Vaccine
- H1N1 Vaccines Market, By Route Of Administration
- Intranasal Vaccine
- Injectable Vaccine
- H1N1 Vaccines Market, By Distribution Channel
- Online Pharmacy
- Hospital Pharmacy
- Retail Pharmacy
Regional Insights
On a global front, the H1N1 Vaccines Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA).
H1N1 Vaccines Market, By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are Abbott Healthcare, CSL Biotherapeutics, ID Biomedical Corporation, Medimmune, Lupin Ltd., AstraZeneca, Sinovac, Cadila Healthcare, GlaxoSmithKline, Sanofi Pasture, Novartis and Serum Institute of India. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Abbott Healthcare
- CSL Biotherapeutics
- ID Biomedical Corporation
- Medimmune
- Lupin Ltd.
- AstraZeneca
- Sinovac
- Cadila Healthcare
- GlaxoSmithKline
- Sanofi Pasture
- Novartis
- Serum Institute of India
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o H1N1 Vaccines Market, By Vaccine Type, Estimates and Forecast, 2017-2027 ($Million)
o Live Attenuated Vaccine
o Inactivated Vaccine
o H1N1 Vaccines Market, By Route Of Administration, Estimates and Forecast, 2017-2027 ($Million)
o Intranasal Vaccine
o Injectable Vaccine
o H1N1 Vaccines Market, By Distribution Channel, Estimates and Forecast, 2017-2027 ($Million)
o Online Pharmacy
o Hospital Pharmacy
o Retail Pharmacy
o H1N1 Vaccines Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America H1N1 Vaccines Market, By Country
o U.S. H1N1 Vaccines Market
o Canada H1N1 Vaccines Market
o Mexico H1N1 Vaccines Market
o Europe
§ Europe H1N1 Vaccines Market, By Country
o Germany H1N1 Vaccines Market
o UK H1N1 Vaccines Market
o France H1N1 Vaccines Market
o Russia H1N1 Vaccines Market
o Italy H1N1 Vaccines Market
o Rest of Europe H1N1 Vaccines Market
o Asia-Pacific
§ Asia-Pacific H1N1 Vaccines Market, By Country
o China H1N1 Vaccines Market
o Japan H1N1 Vaccines Market
o South Korea H1N1 Vaccines Market
o India H1N1 Vaccines Market
o Southeast Asia H1N1 Vaccines Market
o Rest of Asia-Pacific H1N1 Vaccines Market
o South America
§ South America H1N1 Vaccines Market, By Country
o Brazil H1N1 Vaccines Market
o Argentina H1N1 Vaccines Market
o Columbia H1N1 Vaccines Market
o Rest of South America H1N1 Vaccines Market
o Middle East and Africa
§ Middle East and Africa H1N1 Vaccines Market, By Country
o Saudi Arabia H1N1 Vaccines Market
o UAE H1N1 Vaccines Market
o Egypt H1N1 Vaccines Market
o Nigeria H1N1 Vaccines Market
o South Africa H1N1 Vaccines Market
o Rest of MEA H1N1 Vaccines Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. H1N1 Vaccines Market, By Vaccine Type
5.1. Introduction
5.2. Global H1N1 Vaccines Revenue and Market Share by Vaccine Type (2017-2027)
5.2.1. Global H1N1 Vaccines Revenue and Revenue Share by Vaccine Type (2017-2027)
5.3. Live Attenuated Vaccine
5.3.1. Global Live Attenuated Vaccine Revenue and Growth Rate (2017-2027)
5.4. Inactivated Vaccine
5.4.1. Global Inactivated Vaccine Revenue and Growth Rate (2017-2027)
6. H1N1 Vaccines Market, By Route Of Administration
6.1. Introduction
6.2. Global H1N1 Vaccines Revenue and Market Share by Route Of Administration (2017-2027)
6.2.1. Global H1N1 Vaccines Revenue and Revenue Share by Route Of Administration (2017-2027)
6.3. Intranasal Vaccine
6.3.1. Global Intranasal Vaccine Revenue and Growth Rate (2017-2027)
6.4. Injectable Vaccine
6.4.1. Global Injectable Vaccine Revenue and Growth Rate (2017-2027)
7. H1N1 Vaccines Market, By Distribution Channel
7.1. Introduction
7.2. Global H1N1 Vaccines Revenue and Market Share by Distribution Channel (2017-2027)
7.2.1. Global H1N1 Vaccines Revenue and Revenue Share by Distribution Channel (2017-2027)
7.3. Online Pharmacy
7.3.1. Global Online Pharmacy Revenue and Growth Rate (2017-2027)
7.4. Hospital Pharmacy
7.4.1. Global Hospital Pharmacy Revenue and Growth Rate (2017-2027)
7.5. Retail Pharmacy
7.5.1. Global Retail Pharmacy Revenue and Growth Rate (2017-2027)
8. H1N1 Vaccines Market, By Region
8.1. Introduction
8.2. Global H1N1 Vaccines Revenue and Market Share by Regions
8.2.1. Global H1N1 Vaccines Revenue by Regions (2017-2027)
8.3. North America H1N1 Vaccines by Countries
8.3.1. North America H1N1 Vaccines Revenue and Growth Rate (2017-2027)
8.3.2. North America H1N1 Vaccines Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe H1N1 Vaccines by Countries
8.4.1. Europe H1N1 Vaccines Revenue and Growth Rate (2017-2027)
8.4.2. Europe H1N1 Vaccines Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific H1N1 Vaccines by Countries
8.5.1. Asia-Pacific H1N1 Vaccines Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific H1N1 Vaccines Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America H1N1 Vaccines by Countries
8.6.1. South America H1N1 Vaccines Revenue and Growth Rate (2017-2027)
8.6.2. South America H1N1 Vaccines Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa H1N1 Vaccines by Countries
8.7.1. Middle East and Africa H1N1 Vaccines Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa H1N1 Vaccines Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Abbott Healthcare
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. CSL Biotherapeutics
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. ID Biomedical Corporation
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Medimmune
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Lupin Ltd.
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. AstraZeneca
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. Sinovac
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. Cadila Healthcare
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. GlaxoSmithKline
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
9.10. Sanofi Pasture
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Revenue and Market Share
9.11. Novartis
9.11.1. Business Overview
9.11.2. Service Portfolio
9.11.3. Strategic Developments
9.11.4. Revenue and Market Share
9.12. Serum Institute of India
9.12.1. Business Overview
9.12.2. Service Portfolio
9.12.3. Strategic Developments
9.12.4. Revenue and Market Share
10. Global H1N1 Vaccines Market Competition, by Manufacturer
10.1. Global H1N1 Vaccines Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global H1N1 Vaccines Price By Region (2017-2017)
10.3. Top 5 H1N1 Vaccines Manufacturer Market Share
10.4. Market Competition Trend
11. H1N1 Vaccines Market Forecast (2017-2027)
11.1. Global H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. H1N1 Vaccines Market Forecast by Regions (2017-2027)
11.2.1. North America H1N1 Vaccines Market Forecast (2017-2027)
11.2.1.1. United States H1N1 Vaccines Market Forecast (2017-2027)
11.2.1.2. Canada H1N1 Vaccines Market Forecast (2017-2027)
11.2.1.3. Mexico H1N1 Vaccines Market Forecast (2017-2027)
11.2.2. Europe H1N1 Vaccines Market Forecast (2017-2027)
11.2.2.1. Germany H1N1 Vaccines Market Forecast (2017-2027)
11.2.2.2. France H1N1 Vaccines Market Forecast (2017-2027)
11.2.2.3. UK H1N1 Vaccines Market Forecast (2017-2027)
11.2.2.4. Russia H1N1 Vaccines Market Forecast (2017-2027)
11.2.2.5. Italy H1N1 Vaccines Market Forecast (2017-2027)
11.2.2.6. Rest of Europe H1N1 Vaccines Market Forecast (2017-2027)
11.2.3. Asia-Pacific H1N1 Vaccines Market Forecast (2017-2027)
11.2.3.1. China H1N1 Vaccines Market Forecast (2017-2027)
11.2.3.2. Japan H1N1 Vaccines Market Forecast (2017-2027)
11.2.3.3. Korea H1N1 Vaccines Market Forecast (2017-2027)
11.2.3.4. India H1N1 Vaccines Market Forecast (2017-2027)
11.2.3.5. Southeast Asia H1N1 Vaccines Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific H1N1 Vaccines Market Forecast (2017-2027)
11.2.4. South America H1N1 Vaccines Market Forecast (2017-2027)
11.2.4.1. Brazil H1N1 Vaccines Market Forecast (2017-2027)
11.2.4.2. Argentina H1N1 Vaccines Market Forecast (2017-2027)
11.2.4.3. Columbia H1N1 Vaccines Market Forecast (2017-2027)
11.2.4.4. Rest of South America H1N1 Vaccines Market Forecast (2017-2027)
11.2.5. Middle East and Africa H1N1 Vaccines Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia H1N1 Vaccines Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates H1N1 Vaccines Market Forecast (2017-2027)
11.2.5.3. Egypt H1N1 Vaccines Market Forecast (2017-2027)
11.2.5.4. Nigeria H1N1 Vaccines Market Forecast (2017-2027)
11.2.5.5. South Africa H1N1 Vaccines Market Forecast (2017-2027)
11.2.5.6. Turkey H1N1 Vaccines Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa H1N1 Vaccines Market Forecast (2017-2027)
11.3. H1N1 Vaccines Market Forecast by Vaccine Type (2017-2027)
11.3.1. H1N1 Vaccines Forecast by Vaccine Type (2017-2027)
11.3.2. H1N1 Vaccines Market Share Forecast by Vaccine Type (2017-2027)
11.4. H1N1 Vaccines Market Forecast by Route Of Administration (2017-2027)
11.4.1. H1N1 Vaccines Forecast by Route Of Administration (2017-2027)
11.4.2. H1N1 Vaccines Market Share Forecast by Route Of Administration (2017-2027)
11.5. H1N1 Vaccines Market Forecast by Distribution Channel (2017-2027)
11.5.1. H1N1 Vaccines Forecast by Distribution Channel (2017-2027)
11.5.2. H1N1 Vaccines Market Share Forecast by Distribution Channel (2017-2027)
12. List of Tables and Figures
Figure United States H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure France H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure China H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure India H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa H1N1 Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Table Global H1N1 Vaccines Revenue and Revenue Share by Vaccine Type (2017-2027)
Figure Global Live Attenuated Vaccine Revenue and Growth Rate (2017-2027)
Figure Global Inactivated Vaccine Revenue and Growth Rate (2017-2027)
Table Global H1N1 Vaccines Revenue and Revenue Share by Route Of Administration (2017-2027)
Figure Global Intranasal Vaccine Revenue and Growth Rate (2017-2027)
Figure Global Injectable Vaccine Revenue and Growth Rate (2017-2027)
Table Global H1N1 Vaccines Revenue and Revenue Share by Distribution Channel (2017-2027)
Figure Global Online Pharmacy Revenue and Growth Rate (2017-2027)
Figure Global Hospital Pharmacy Revenue and Growth Rate (2017-2027)
Figure Global Retail Pharmacy Revenue and Growth Rate (2017-2027)
Table Global H1N1 Vaccines Revenue by Regions (2017-2027)
Figure North America H1N1 Vaccines Growth Rate (2017-2027)
Figure North America H1N1 Vaccines Revenue and Growth Rate (2017-2027)
Figure North America H1N1 Vaccines by Countries (2017-2027)
Figure North America H1N1 Vaccines Revenue (Million USD) by Countries (2017-2027)
Figure United States H1N1 Vaccines Growth Rate (2017-2027)
Figure United States H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Canada H1N1 Vaccines Growth Rate (2017-2027)
Figure Canada H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Mexico H1N1 Vaccines Growth Rate (2017-2027)
Figure Mexico H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Europe H1N1 Vaccines Growth Rate (2017-2027)
Figure Europe H1N1 Vaccines Revenue and Growth Rate (2017-2027)
Figure Europe H1N1 Vaccines by Countries (2017-2027)
Figure Europe H1N1 Vaccines Revenue (Million USD) by Countries (2017-2027)
Figure Germany H1N1 Vaccines Growth Rate (2017-2027)
Figure Germany H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure France H1N1 Vaccines Growth Rate (2017-2027)
Figure France H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure UK H1N1 Vaccines Growth Rate (2017-2027)
Figure UK H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Russia H1N1 Vaccines Growth Rate (2017-2027)
Figure Russia H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Italy H1N1 Vaccines Growth Rate (2017-2027)
Figure Italy H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Rest of Europe H1N1 Vaccines Growth Rate (2017-2027)
Figure Rest of Europe H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Asia-Pacific H1N1 Vaccines Growth Rate (2017-2027)
Figure Asia-Pacific H1N1 Vaccines Revenue and Growth Rate (2017-2027)
Figure Asia-Pacific H1N1 Vaccines by Countries (2017-2027)
Figure Asia-Pacific H1N1 Vaccines Revenue (Million USD) by Countries (2017-2027)
Figure China H1N1 Vaccines Growth Rate (2017-2027)
Figure China H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Japan H1N1 Vaccines Growth Rate (2017-2027)
Figure Japan H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Korea H1N1 Vaccines Growth Rate (2017-2027)
Figure Korea H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure India H1N1 Vaccines Growth Rate (2017-2027)
Figure India H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Southeast Asia H1N1 Vaccines Growth Rate (2017-2027)
Figure Southeast Asia H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific H1N1 Vaccines Growth Rate (2017-2027)
Figure Rest of Asia-Pacific H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure South America H1N1 Vaccines Growth Rate (2017-2027)
Figure South America H1N1 Vaccines Revenue and Growth Rate (2017-2027)
Figure South America H1N1 Vaccines by Countries (2017-2027)
Figure South America H1N1 Vaccines Revenue (Million USD) by Countries (2017-2027)
Figure Brazil H1N1 Vaccines Growth Rate (2017-2027)
Figure Brazil H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Argentina H1N1 Vaccines Growth Rate (2017-2027)
Figure Argentina H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Columbia H1N1 Vaccines Growth Rate (2017-2027)
Figure Columbia H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Rest of South America H1N1 Vaccines Growth Rate (2017-2027)
Figure Rest of South America H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Middle East and Africa H1N1 Vaccines Growth Rate (2017-2027)
Figure Middle East and Africa H1N1 Vaccines Revenue and Growth Rate (2017-2027)
Figure Middle East and Africa H1N1 Vaccines by Countries (2017-2027)
Figure Middle East and Africa H1N1 Vaccines Revenue (Million USD) by Countries (2017-2027)
Figure Saudi Arabia H1N1 Vaccines Growth Rate (2017-2027)
Figure Saudi Arabia H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure United Arab Emirates H1N1 Vaccines Growth Rate (2017-2027)
Figure United Arab Emirates H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Egypt H1N1 Vaccines Growth Rate (2017-2027)
Figure Egypt H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Nigeria H1N1 Vaccines Growth Rate (2017-2027)
Figure Nigeria H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure South Africa H1N1 Vaccines Growth Rate (2017-2027)
Figure South Africa H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Turkey H1N1 Vaccines Growth Rate (2017-2027)
Figure Turkey H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa H1N1 Vaccines Growth Rate (2017-2027)
Figure Rest of Middle East and Africa H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Table Abbott Healthcare H1N1 Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table CSL Biotherapeutics H1N1 Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ID Biomedical Corporation H1N1 Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Medimmune H1N1 Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Lupin Ltd. H1N1 Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AstraZeneca H1N1 Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sinovac H1N1 Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cadila Healthcare H1N1 Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithKline H1N1 Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi Pasture H1N1 Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novartis H1N1 Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Serum Institute of India H1N1 Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global H1N1 Vaccines Market Share by Manufacturer
Figure Global H1N1 Vaccines Revenue and Market Share by Manufacturer
Table Global H1N1 Vaccines Price by Region (2017-2017)
Figure Top 5 H1N1 Vaccines Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global H1N1 Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
Table H1N1 Vaccines Market Forecast by Regions (2017-2027)
Figure North America H1N1 Vaccines Market Forecast (2017-2027)
Figure United States H1N1 Vaccines Market Forecast (2017-2027)
Figure Canada H1N1 Vaccines Market Forecast (2017-2027)
Figure Mexico H1N1 Vaccines Market Forecast (2017-2027)
Figure Europe H1N1 Vaccines Market Forecast (2017-2027)
Figure Germany H1N1 Vaccines Market Forecast (2017-2027)
Figure France H1N1 Vaccines Market Forecast (2017-2027)
Figure UK H1N1 Vaccines Market Forecast (2017-2027)
Figure Russia H1N1 Vaccines Market Forecast (2017-2027)
Figure Italy H1N1 Vaccines Market Forecast (2017-2027)
Figure Rest of Europe H1N1 Vaccines Market Forecast (2017-2027)
Figure Asia-Pacific H1N1 Vaccines Market Forecast (2017-2027)
Figure China H1N1 Vaccines Market Forecast (2017-2027)
Figure Japan H1N1 Vaccines Market Forecast (2017-2027)
Figure Korea H1N1 Vaccines Market Forecast (2017-2027)
Figure India H1N1 Vaccines Market Forecast (2017-2027)
Figure Southeast Asia H1N1 Vaccines Market Forecast (2017-2027)
Figure Rest of Asia-Pacific H1N1 Vaccines Market Forecast (2017-2027)
Figure South America H1N1 Vaccines Market Forecast (2017-2027)
Figure Brazil H1N1 Vaccines Market Forecast (2017-2027)
Figure Argentina H1N1 Vaccines Market Forecast (2017-2027)
Figure Columbia H1N1 Vaccines Market Forecast (2017-2027)
Figure Rest of South America H1N1 Vaccines Market Forecast (2017-2027)
Figure Middle East and Africa H1N1 Vaccines Market Forecast (2017-2027)
Figure Saudi Arabia H1N1 Vaccines Market Forecast (2017-2027)
Figure United Arab Emirates H1N1 Vaccines Market Forecast (2017-2027)
Figure Egypt H1N1 Vaccines Market Forecast (2017-2027)
Figure Nigeria H1N1 Vaccines Market Forecast (2017-2027)
Figure South Africa H1N1 Vaccines Market Forecast (2017-2027)
Figure Turkey H1N1 Vaccines Market Forecast (2017-2027)
Figure Rest of Middle East and Africa H1N1 Vaccines Market Forecast (2017-2027)
Figure Global H1N1 Vaccines Forecast by Vaccine Type (2017-2027)
Figure Global H1N1 Vaccines Market Share Forecast by Vaccine Type (2017-2027)
Figure Global H1N1 Vaccines Forecast by Vaccine Type (2017-2027)
Figure Global H1N1 Vaccines Forecast by Route Of Administration (2017-2027)
Figure Global H1N1 Vaccines Market Share Forecast by Route Of Administration (2017-2027)
Figure Global H1N1 Vaccines Forecast by Route Of Administration (2017-2027)
Figure Global H1N1 Vaccines Forecast by Distribution Channel (2017-2027)
Figure Global H1N1 Vaccines Market Share Forecast by Distribution Channel (2017-2027)
Figure Global H1N1 Vaccines Forecast by Distribution Channel (2017-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|